Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease

Chandana Guha(The University of Sydney), Germaine Wong(Children's Hospital at Westmead), Charani Kiriwandeniya(The University of Queensland), Elizabeth Ryan(Cancer Research And Biostatistics), Michelle Irving(New South Wales Department of Health), Luke Macauley(Kidney Health Australia), Rabia Khalid(The University of Sydney), Fiona Mackie, Steven McTaggart, Nicholas Larkins, Deirdré Hahn(Children's Hospital at Westmead), Donna Reidlinger(Translational Research Institute), Jonathan C. Craig(Flinders University), Seán Kennedy(Environmental Protection Agency), David W. Johnson(Hennepin County), Armando Teixeira‐Pinto(The University of Sydney), Hugh J. McCarthy(University of Bristol), Shilpanjali Jesudason(South Australia Pathology), Alistair R. Mallard(The University of Queensland), Reginald Woodleigh(Prostate Cancer Foundation of Australia), Anna Francis(Children's Health Queensland Hospital and Health Service), Patrina Caldwell(Children's Hospital at Westmead), Kirsten Howard(The University of Sydney), Stephen I. Alexander(University of South Australia), Amélie Bernier-Jean(Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal), Martin Howell(UNSW Sydney), Anita van Zwieten(The University of Sydney), Carmel M. Hawley(The University of Queensland), Julie Varghese(The University of Queensland), Amanda Walker(Royal Children's Hospital), Elaine M. Pascoe(The University of Queensland), Allison Jauré(The University of Sydney), Simon Carter(Royal Children's Hospital)
Pediatric Nephrology
October 20, 2022
Cited by 5


Related Papers